Terkko Navigator / -/ Feeds / "curr vasc pharmacol "

ErbB Targeted Drugs and Angiogenesis.

Cardiac Biomarkers in Acute Coronary Syndromes: A Review.

Role of Vascular Endothelial Growth Factor in Kidney Disease.

Potential Effect of Anti-Tumour Necrosis Factor-Alpha Treatment on Reducing the Cardiovascular Risk Related to Rheumatoid Arthritis.

Current management of intermittent claudication: the role of pharmacological and nonpharmacological symptom-directed therapies.

Pharmacological agents in the treatment of venous disease: an update of the available evidence.

ESVS Guidelines: Section A - Prevention in Patients with Carotid Artery Stenosis, on Behalf of the ESVS Guidelines Collaborators.

ESVS Guidelines: Section B - Diagnosis and Investigation of Patients with Carotid Stenosis, on behalf of the ESVS Guidelines Collaborators.

Total Knee Replacement and Chemical Thromboprophylaxis: Current Evidence.

Cellular and Molecular Mechanisms of Low Cardiac Output Syndrome after Pediatric Cardiac Surgery.

Ethnic and Geographical Differences in Ischaemic Stroke Among Young Adults.

Ethnic and Geographical Differences in Ischaemic Stroke Among Young Adults.

Animal Models of Focal Cerebral Ischaemia and Haemorrhagic Transformation: Considerations in Experimental Stroke Study Design.

Familial Hypercholesterolaemia Registry in the MENA Region.

Improving Adherence to Ticagrelor in Patients After Acute Coronary Syndrome: Talking Face to Face is Better than a Phone Call.

Cushing's Syndrome and Cardiovascular Risk.

Diabetes Mellitus and Acute Coronary Syndrome: A Lethal Combination Requiring Better Therapeutic Strategies.

Role of nicotinic acetylcholine receptors in cardiovascular physiology and pathophysiology: current trends and perspectives.

Cardiovascular risk and quality of life in autosomal dominant polycystic kidney disease patients in therapy with tolvaptan: A pilot study.

Pharmacological Management of Cardiac Disease in Patients with Type 2 Diabetes: Insights into Clinical Practice.

Pharmacological Management of Type 2 Diabetes Complications.

Comparison of Clinical Features at the Onset of Takayasu's Arteritis According to Age and Sex.

Treatment of Diabetic Cardiovascular Autonomic, Peripheral and Painful Neuropathy. Focus on the Treatment of Cardiovascular Autonomic Neuropathy with ACE Inhibitors.

Microvascular Complications of Type 2 Diabetes Mellitus.

Advances in Dermoepidermal Skin Substitutes for Diabetic Foot Ulcers.

The Incidence of Adverse Drug Reactions in Patients Treated with Statins in the Emirates: A Retrospective Cohort Study.

Diabetes and Heart Failure: Is it Hyperglycemia or Hyperinsulinemia?

The Growing Epidemic of Diabetes Mellitus.

Pharmacological Management of Diabetic Nephropathy.

Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block.

Macrovascular Complications of Type 2 Diabetes Mellitus.

Effects of Lipid Lowering Drugs on Arterial Stiffness: One More Way to Reduce Cardiovascular Risk?

Effect of Early Normotension with Olmesartan on Rho-kinase Activity in Hypertensive Patients.

Long-Term Outcome of Acute Coronary Syndromes in Patients on Chronic Oral Anticoagulants: Data from the EPICOR Study.

Endothelial and Cardiac Dysfunction in Inflammatory Bowel Diseases: Does Treatment Modify the Inflammatory Load on Arterial and Cardiac Structure and Function?

Diabetes and Mortality in Acute Coronary Syndrome: Findings from the Gulf COAST Registry.

The Gulf Familial Hypercholesterolemia Registry (Gulf FH): Design, Rationale and Preliminary Results.

Should Cushing's Syndrome be Considered as a Disease with High Cardiovascular Risk in Relevant Guidelines?

Smoking and Endothelial Dysfunction.

Cardiovascular Autonomic Neuropathy and Distal Symmetric Sensorimotor Polyneuropathy: These Two Diabetic Microvascular Complications do not Invariably Co-Exist.

Regional Distribution of Nitric Oxide Synthase in Human Anorectal Tissue: A Pilot Study on the Potential Role for Nitric Oxide in Haemorrhoids.

Editorial on Prevalence, Diagnosis and Treatment with 3 Different Statins of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?

Prevalence, diagnosis and treatment with 3 different statins of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis in military personnel. Do genetics play a role?

Diabetic Cardiomyopathy: Clinical and Metabolic Approach.

Cardioprotective effects of natural products via the Nrf2 signaling path-way.

Pre- and post-conditioning of the heart: an overview of cardioprotective signaling pathways.

Adherence to treatment, arterial stiffness and cognitive function in irbesartan-treated newly diagnosed hypertensive patients.

Statins and Non-Alcoholic Fatty Liver Disease Progression: Further Comments.

Exploring the High Burden of Cardiovascular Disease Among Patients with End-Stage Renal Disease.